Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

BVMF/BIIB34 stock hub

BVMF/BIIB34 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BVMF/BIIB34is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

139.9B

Brazil Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BVMF/BIIB34

In the news

Latest news · BVMF/BIIB34

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E13.5

P25 11.3P50 14.6P75 19.6

Trailing P/E19.5

P25 15.2P50 21.5P75 27.3

ROE7.7

P25 5.3P50 12.3P75 22.5

ROIC10.9

P25 7P50 12.5P75 22.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BVMF/BIIB34 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

217

Groups with data

Currency

USD

Showing 217 of 217 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	BR
Employees	7,500
Employees Change	-105%
Employees Change Percent	-1.38
Enterprise value	BRL 148.8B
Exchange	Brazil Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - General
Last refreshed	2026-05-10
Market cap	BRL 139.9B
Price	BRL 158
Price currency	BRL
Rev Per Employee	6,912,091.07x
Sector	Healthcare
Sic	2836
Symbol	bvmf/BIIB34
Website	https://www.biogen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.12%
EV Earnings	20.79x
EV/EBIT	11.19x
EV/EBITDA	8.35x
EV/FCF	11.77x
EV/Sales	3.06x
FCF yield	9.04%
Forward P/E	13.49x
P/B ratio	1.44x
P/E ratio	19.54x
P/S ratio	2.7x
PE Ratio10 Y	16.99x
PE Ratio3 Y	19.86x
PE Ratio5 Y	19.53x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	27.32%
EBITDA Margin	35.38%
FCF margin	24.38%
Gross margin	78.72%
Gross Profit	BRL 40.8B
Gross Profit Growth	2.83%
Gross Profit Growth Q	0.78%
Gross Profit Growth3 Y	-0.4%
Gross Profit Growth5 Y	-6.2%
Net Income	BRL 7.2B
Net Income Growth	-7.26%
Net Income Growth Q	32.85%
Net Income Growth3 Y	-24.05%
Net Income Growth5 Y	-14.55%
Pretax Margin	16.33%
Profit Margin	13.81%
Profit Per Employee	BRL 954,243
ROA	5.9
Roa5y	6.65
ROCE	10.25
ROE	7.7
Roe5y	13.26
ROIC	10.92
Roic5y	13.81

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-0.38%
Cagr1y	42.14%
Cagr3y	-15.25%
Cagr5y	-8%
EPS Growth	-8.1
EPS Growth Q	31.1
EPS Growth3 Y	-24.42
EPS Growth5 Y	-13.58
FCF Growth	-0.57%
FCF Growth Q	167.46%
FCF Growth3 Y	19.25%
FCF Growth5 Y	-5.2%
OCF Growth	0.36%
OCF Growth Q	148.94%
OCF Growth10 Y	-4.25%
OCF Growth3 Y	15.58%
OCF Growth5 Y	-6.01%
Revenue Growth	1.23x
Revenue Growth Q	1.93x
Revenue Growth3 Y	-0.55x
Revenue Growth5 Y	-4.64x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	BRL 0.35
Assets	BRL 153.8B
Cash	BRL 22.3B
Current Assets	BRL 45.2B
Current Liabilities	BRL 14.7B
Debt	BRL 34.2B
Debt EBITDA	BRL 1.8
Debt Equity	BRL 0.35
Debt FCF	BRL 2.71
Equity	BRL 97.3B
Interest Coverage	9.87
Liabilities	BRL 56.5B
Long Term Assets	BRL 108.6B
Long Term Liabilities	BRL 41.8B
Net Cash	BRL -9.5B
Net Cash By Market Cap	BRL -6.76
Net Debt EBITDA	BRL 0.52
Net Debt Equity	BRL 0.1
Net Debt FCF	BRL 0.75
Tangible Book Value	BRL 16.2B
Tangible Book Value Per Share	BRL 110
WACC	4.83

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.06
Inventory Turnover	1
Net Working Capital	BRL 10B
Quick ratio	2.03
Working Capital	BRL 32.3B
Working Capital Turnover	BRL 12.17

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.01%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-3.73%
1Y total return	42.11%
200-day SMA	143.1
3Y total return	-39.14%
50-day SMA	157.9
50-day SMA vs 200-day SMA	50over200
5Y total return	-34.07%
All Time High	360
All Time High Change	-56.09%
All Time High Date	2020-11-06
All Time Low	110.1
All Time Low Change	43.62%
All Time Low Date	2025-04-10
ATR	3.47
Beta	0.16
Ch YTD	-1.81
High	158.1
High52	172.3
High52 Date	2026-02-13
High52ch	-8.23%
Low	157.1
Low52	111.7
Low52 Date	2025-05-09
Low52ch	42.11%
Ma50ch	0.1%
Price vs 200-day SMA	10.46%
RSI	52.04
RSI Monthly	48.99
RSI Weekly	51.94
Sharpe ratio	-0.43x
Sortino ratio	-0.52
Total Return	-1.01%
Tr YTD	-1.81
Tr1m	4.86%
Tr1w	1.65%
Tr3m	-2.3%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	BRL 14.2B
Operating Income Growth	4.02
Operating Income Growth Q	-16.14
Operating Income Growth3 Y	-2.11
Operating Income Growth5 Y	-6.25
Operating margin	27.32

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	147,154,881%
Net Borrowing	-1,459,025,980
Shares Insiders	0.2%
Shares Institutions	98.16%
Shares Qo Q	1.16%
Shares Yo Y	1.01%
Short Ratio	3.95

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	BRL 11.1B
Average Volume	33.7x
Bv Per Share	659.2
CAPEX	BRL -875.9M
Ch10y	-3.73
Ch1m	4.86
Ch1w	1.65
Ch1y	42.11
Ch3m	-2.3
Ch3y	-39.14
Ch5y	-34.07
Ch6m	12.8
Change	1.01%
Change From Open	0.61
Close	156.5
Days Gap	0.4
Depreciation Amortization	3,936,765,620
Dollar Volume	4,110.1
Earnings Date	2026-04-29
EBIT	BRL 14.2B
EBITDA	BRL 18.3B
EPS	BRL 48.5
F Score	6
FCF	BRL 12.6B
FCF EV Yield	8.5x
Financing CF	-1,683,437,158
Fiscal Year End	December
Founded	1,978
Goodwill	31,886,769,540
Graham Number	141.46173
Graham Upside	-10.51
Income Tax	BRL 1.3B
Investing CF	-7,998,804,443
Is Primary Listing	0
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Lynch Fair Value	BRL 40.44
Lynch Upside	-74.42
Ma150	140.4
Ma150ch	12.62%
Ma20	157
Ma20ch	0.69%
Net CF	4,091,999,090
Next Earnings Date	2026-07-29
Open	157.1
P FCF Ratio	11.07
P OCF Ratio	10.35
Position In Range	100
Ppne	16,065,502,640
Price Date	2026-05-08
Price EBITDA	BRL 7.63
Ptbv Ratio	8.62
Relative Volume	0.81x
Revenue	51,840,683,015x
SBC By Revenue	2.96x
Share Based Comp	1,532,673,805
Tax By Revenue	2.53x
Tax Rate	15.47%
Tr6m	12.8%
Volume	26
Z Score	3.12

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BVMF/BIIB34 pay a dividend?

Capital-return profile for this ticker.

Performance

BVMF/BIIB34 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BVMF/BIIB34?

Insider, institutional, and short-interest positioning.

Institutional ownership

+98.2%

Share of float held by funds and institutions

Insider ownership

+0.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BVMF/BIIB34 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

52.0

Neutral momentum band

Price vs 200-day MA

+10.5%

50/200-day relationship not available

Beta (5Y)

0.16

Less volatile than the market

Sharpe ratio

-0.43

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BVMF/BIIB34

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bvmf/BIIB34 stock rating?

bvmf/BIIB34 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bvmf/BIIB34 analysis?

The full report lives at /stocks/bvmf/BIIB34/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bvmf/BIIB34?

The latest report frames bvmf/BIIB34 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bvmf/BIIB34 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.